Clinical Trial: Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Major Depressive Disorder
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as an Adjunctive Treatment for Major Depressive Disorder (RELIGHT)
Brief Summary:
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).
Read more